| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.0008 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |